Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

The furin cleavage site is required for pathogenesis, but not transmission of SARS-CoV-2

Angelica L. Morgan, Michelle N. Vu, View ORCID ProfileYiyang Zhou, Kumari G. Lokugamage, William M. Meyers, R. Elias Alvarado, Yani Ahearn, Leah K. Estes, Jessica A. Plante, Bryan A. Johnson, View ORCID ProfileMehul S. Suthar, David H Walker, Ken S. Plante, Vineet D. Menachery
doi: https://doi.org/10.1101/2025.03.10.642264
Angelica L. Morgan
1Experimental Pathology Graduate Program, University of Texas Medical Branch, Galveston, TX, United States
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
9Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.,
10Emory Vaccine Center, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle N. Vu
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiyang Zhou
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
9Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.,
10Emory Vaccine Center, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yiyang Zhou
Kumari G. Lokugamage
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William M. Meyers
1Experimental Pathology Graduate Program, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Elias Alvarado
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
3Human Pathophysiology and Translational Medicine, University of Texas Medical Branch, Galveston, TX, United States
4Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yani Ahearn
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leah K. Estes
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica A. Plante
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
5World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX
6Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan A. Johnson
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehul S. Suthar
9Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.,
10Emory Vaccine Center, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mehul S. Suthar
David H Walker
6Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, United States
7Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States
8Center for Biodefenses and Emerging Infectious Disease, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken S. Plante
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
5World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX
6Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vineet D. Menachery
2Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, United States
4Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, United States
9Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.,
10Emory Vaccine Center, Emory University, Atlanta, GA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Vineet.D.Menachery{at}emory.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

The SARS-CoV-2 spike, key to viral entry, has two features that differentiate it from other sarbecoviruses: the presence of a furin cleavage site (FCS; PRRAR sequence) and an extended S1/S2 loop characterized by an upstream QTQTN amino acid motif. Our prior works show that shortening the S1/S2 loop by deleting either the FCS (ΔPRRA) or deleting an upstream sequence (ΔQTQTN), ablates spike processing, alters host protease usage, and attenuates infection in vitro and in vivo. With the importance of the loop length established, here we evaluated the impact of disrupting the FCS, but preserving the S1/S2 loop length. Using reverse genetics, we generated a SARS-CoV-2 mutant that disrupts the FCS (PQQAR) but maintains its extended S1/S2 loop. The SARS-CoV-2 PQQAR mutant has reduced replication, decreased spike processing, and attenuated disease in vivo compared to wild-type SARS-CoV-2. These data, similar to the FCS deletion mutant, indicate that loss of the furin cleavage site attenuates SARS-CoV-2 pathogenesis. Importantly, we subsequently found that the PQQAR mutant is transmitted in the direct contact hamster model despite lacking an intact FCS. However, competition transmission showed that the mutant was attenuated compared to WT SARS-CoV-2. Together, the data argue that the FCS is required for SARS-CoV-2 pathogenesis but is not strictly required for viral transmission.

Competing Interest Statement

VDM has filed a patent on the reverse genetic system for SARS-CoV-2. All other authors declare no conflicts of interest. Other authors declare no competing interests.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted March 11, 2025.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The furin cleavage site is required for pathogenesis, but not transmission of SARS-CoV-2
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The furin cleavage site is required for pathogenesis, but not transmission of SARS-CoV-2
Angelica L. Morgan, Michelle N. Vu, Yiyang Zhou, Kumari G. Lokugamage, William M. Meyers, R. Elias Alvarado, Yani Ahearn, Leah K. Estes, Jessica A. Plante, Bryan A. Johnson, Mehul S. Suthar, David H Walker, Ken S. Plante, Vineet D. Menachery
bioRxiv 2025.03.10.642264; doi: https://doi.org/10.1101/2025.03.10.642264
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The furin cleavage site is required for pathogenesis, but not transmission of SARS-CoV-2
Angelica L. Morgan, Michelle N. Vu, Yiyang Zhou, Kumari G. Lokugamage, William M. Meyers, R. Elias Alvarado, Yani Ahearn, Leah K. Estes, Jessica A. Plante, Bryan A. Johnson, Mehul S. Suthar, David H Walker, Ken S. Plante, Vineet D. Menachery
bioRxiv 2025.03.10.642264; doi: https://doi.org/10.1101/2025.03.10.642264

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Microbiology
Subject Areas
All Articles
  • Animal Behavior and Cognition (7510)
  • Biochemistry (17266)
  • Bioengineering (13500)
  • Bioinformatics (41002)
  • Biophysics (21024)
  • Cancer Biology (18140)
  • Cell Biology (24965)
  • Clinical Trials (138)
  • Developmental Biology (13165)
  • Ecology (19538)
  • Epidemiology (2067)
  • Evolutionary Biology (23975)
  • Genetics (15414)
  • Genomics (22148)
  • Immunology (17380)
  • Microbiology (39639)
  • Molecular Biology (16820)
  • Neuroscience (86858)
  • Paleontology (658)
  • Pathology (2777)
  • Pharmacology and Toxicology (4704)
  • Physiology (7485)
  • Plant Biology (14812)
  • Scientific Communication and Education (2021)
  • Synthetic Biology (4196)
  • Systems Biology (9647)
  • Zoology (2233)